Figure 3: Alcian blue staining was positive in the myxoid stroma (Alcian blue; x200).
Written informed consent was obtained from the patient who was presented in this case report.
Yang et al. [1] have identified the histological criteria of the diagnosis of MSC SCC by using 6 cases. The inclusion criteria of MSC SCC include significant myxoid stromal changes occurring in more than half of the lesion, positive staining for neoplastic spindle (and squamous) cells with a minimum of one cytokeratin (CK) and especially high molecular weight CK (HMWCK), and negative staining for melanocytic and mesenchymal markers of neoplastic cells (S-100, MART-1, actin, myogenin, and desmin). The first 3 criteria were met in all 6 cases. Similar to the histological criteria identified by Yang et al., our case showed negative staining with mesencyhmal and melanocytic markers and positive staining with epithelial markers, and there was mucin production in more than half of the lesion. Since MSS SCC is a rarely seen type of carcinoma, it is very difficult to determine the prognosis. Local recurrence was identified in a limited number of cases by Yang et al. and metastasis was observed in one case. They reported that the invasion depth of the tumor was the most important indicator of an aggressive course [1].
The differential diagnosis of MSS SCC includes myxoid sarcomas (such as myxofibrosarcoma and malignant peripheral nerve sheath tumor), spindle cell atypical fibroxanthoma (AFX) and spindle cell melanoma. The negativity of melanocytic and mesenchymal markers excludes these tumors. However, only vimentin among the mesenchymal markers shows positive staining in spindle cell SCC [1-3].
MSC SCC differs from other cutaneous and mucocutaneous SCCs. MSC SCC lacks mucin-containing glandular structures in contrast to adenosquamous SCC. Adenosquamous carcinoma SCC is characterized by the presence of squamous cells, mucin-producing cells and, in some cases, glandular structures [3,7,8]. The intracellular mucin in adenosquamous carcinoma is epithelial mucin (sialomucin) and stains with mucicarmine, and the glandular structures express CEA when present [3]. MSC SCC is characterized by a mucinous (myxoid) stroma that is positive with Alcian blue but true epithelial type mucin is not observed (mucicarmine should be negative). In addition, signet ring-like cells were a minor component but no intracytoplasmic mucin was detected within these tumor cells. Thus, unlike cutaneous SCC with mucinous metaplasia (also referred to as signet ring cell SCC), MSC SCC lacks signet ring cells with intracytoplasmic mucin [8].
The chronic long-term exposure to ultraviolet (UV) radiation has been reported to be responsible for the pathogenesis of most SCCs [5]. It has been reported that long-term UV exposure likely plays the key instigator role in the epithelial-mesencyhmal transition pathways causing the phenotypic changes observed in spindle cell SCC. HPV plays a major role in SCCs localized in the genital region. Although HPV DNA can be found in 45% of all penile and vulvar SCCs, the highest incidence of HPV DNA is seen in basaloid-type penile SCC cases [9]. In our case, the condition was localized to the scalp and there was exposure to UV radiation.
In conclusion, we describe an unusual variant of spindle cell SCC with prominent myxoid features that may mimic myxoid AFX, myxoid sarcomas and, less frequently, melanoma with myxoid change. The differential diagnosis of spindle cell SCCs with myxoid stroma should be made by using melanocytic and mesenchymal markers in order to distinguish them from all the other potential tumors, and the diagnosis should be confirmed by using epithelial markers. Moreover, the patients should be followed up for a long time in terms of recurrence and metastasis.
CONFLICT of INTEREST
There are no conflicts of interest.
AUTHORSHIP CONTRIBUTIONS
Concept: RB, Design: RB, Supervision: RB, MS, OS,
Resources: RB, MS, OS, Materials Data Collection and/or
Processing: RB, MS, OS, Analysis and/or Interpretation:
RB, OS, Literature Search: RB, Writing Manuscript: RB,
Critical Review: RB.
1) Yang A, Hanley A, Velazquez EF, Cassarino DS. Primary
cutaneous myxoid spindle cell squamous cell carcinoma: A
clinicopathologic study and review of the literature. J Cutan
Pathol. 2010;37:465-74.
2) Harris CN, Green R, Khan I. Primary cutaneous myxoid spindle
cell squamous cell carcinoma: A rare skin cancer. BMJ Case Rep.
2015;2015:bcr2015212317.
3) Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell
carcinoma: A comprehensive clinicopathologic classificationpart
two. J Cutan Pathol. 2006;33:261-79.
4) Foschini MP, Fulcheri E, Baracchini P,Ceccarelli C, Betts CM,
Eusebi V. Squamous cell carcinoma with prominent myxoid
stroma. Hum Pathol. 1990;21:859-65.
5) Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell
carcinoma: A comprehensive clinicopathologic classification.
Part one. J Cutan Pathol. 2006;33:191-206.
6) Weidner N, Foucar E. Adenosquamous carcinoma of the skin.
An aggressive mucin and gland-forming squamous carcinoma.
Arch Dermatol. 1985;121:775-9.
7) Leventon GS, Evans HL. Sarcomatoid squamous cell carcinoma of
the mucous membranes of the head and neck: A clinicopathologic
study of 20 cases. Cancer. 1981;48:994-1003.